Sun.Aug 18, 2024

article thumbnail

Benzimidazole–Oxadiazole Hybrids—Development in Medicinal Chemistry: An Overview

Chemical Biology and Drug Design

The present work systematically gives a comprehensive review in current developments of benzimidazole–oxadiazole hybrid compounds in the whole range of medicinal chemistry and the perspectives that they hold for future research. ABSTRACT To increase the success rate of drug discovery, one practical strategy is to begin molecular hybridisation. The presence of two or more pharmacophores in a single unit leads to a pharmacological potency greater than the sum of each individual moiety's potency.

article thumbnail

Long Time Passing: Where Have All the De Novo Decision Summaries Gone?

FDA Law Blog: Biosimilars

By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — In 1997, Congress wisely amended the Federal Food, Drug, and Cosmetic Act (FDCA) by adding Section 513(f)(2) to establish the De Novo process. The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use.

FDA 67
article thumbnail

Why Back to School Should Include a Dental Checkup

Drugs.com

SUNDAY, Aug. 18, 2024 -- As kids head back to school this fall, there is probably one item many parents haven't thought to put on the to-do list: dental checkups.But they should make sure their children's teeth are in good shape, said Dr. Natasha.

59
article thumbnail

Putting Patients First: The Shift Towards Patient-Centric Clinical Trials

ProRelix Research

Although time, speed, and operational constraints have long plagued the progress of clinical trials, another factor that remains important and has been gaining prime importance as the centre of clinical […] The post Putting Patients First: The Shift Towards Patient-Centric Clinical Trials appeared first on ProRelix Research.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Salesforce CPQ Advanced Approvals

Perficient: Drug Development

What Is a Salesforce Approval Process An approval process in Salesforce is a set of steps that automate how records are approved in your organization. It specifies the actions to take when records are submitted for approval, who must approve them, and what happens after approval or rejection. This process ensures that important business decisions and changes to records are reviewed and authorized by the right people consistently and efficiently.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

Which pharmaceutical companies have the most SPCs in Spain?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain.